iNova Pharmaceuticals Earns the Best Place To Work Global Certification

SYDNEY–(BUSINESS WIRE)–Jul. 14, 2021 iNova Pharmaceuticals, a company that markets and distributes a wide range of over-the-counter and prescription medicines in Australasia, Asia and Africa, has recently been recognised as one of the best places to work organisations in 2021. iNova achieved outstanding results in a number of assessment areas, and remains committed to using […]

Kyalio Launches DayDay Endo-Laparoscopic VR Surgical Library the First in Asia

SINGAPORE–(BUSINESS WIRE)–Jul. 08, 2021 On July 1st, 2021, Kyalio and the Endoscopic and Laparoscopic Surgeons of Asia (ELSA), a leading surgical association with over 2,600 members, jointly launched the Day-to-Day Endo-Laparoscopic Virtual Reality Surgical Library. A first in Asia, the multi-platform VR Surgical Library, which utilises real-scene Virtual Reality, addresses the importance of continuous surgical […]

Smiths Medical Issues Worldwide Notification Regarding the Recall of Jelco® Hypodermic Needle-Pro® Fixed Needle Insulin Syringe With Skewed Graduation Markings

MINNEAPOLIS–(BUSINESS WIRE)–Jun. 17, 2021 Smiths Medical has become aware of specific models and lots of Jelco® Hypodermic Needle-Pro® Fixed Needle Insulin Syringes that may exhibit skewed odd number line graduation markings on their syringe barrels. Markings skewed approximately 20 degrees upward have been identified. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210616005888/en/ […]

Celltrion announces positive top-line results from global Phase III trial of regdanvimab (CT-P59) an anti-COVID-19 monoclonal antibody treatment

Regdanvimab (CT-P59) (40mg/kg) achieved statistically significant and clinically meaningful results in four main endpoints including primary and three key secondary endpoints; the company anticipates full Phase III data to be released in the coming months Regdanvimab (CT-P59) significantly reduced the risk of COVID-19 related hospitalisation or death by 72% for patients at high- risk of […]

Illumina and Next Generation Genomic Partner to Launch VeriSeq™ NIPT Solution in Thailand

Next-generation Sequencing-based CE-IVD Solution Provides Accurate, Reliable, Fast and Scalable End-to-end Genome-wide Noninvasive Prenatal Testing MELBOURNE, Australia–(BUSINESS WIRE)–Jun. 01, 2021 Illumina, Inc., the global leader in DNA sequencing and array-based technologies and Next Generation Genomic Co., Ltd. (NGG Thailand), the Association of Southeast Asian Nations (ASEAN) leaders in laboratory services and reproductive science, today announced […]

ZOLL and Global Healthcare SG Sign Exclusive Agreement for Distribution of Portable Targeted Temperature Management System in Asia Pacific

CHELMSFORD, Mass.–(BUSINESS WIRE)–Jun. 01, 2021 ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, and Global Healthcare SG, a developer of portable body cooling solutions, today announced their exclusive distribution agreement. As part of the agreement, ZOLL has exclusive rights to distribute the CarbonCool® Full Body Suit and Comfort […]

Bluestar Genomics Closes $70M Series C Funding Expands Scientific Advisory Board

Additional Funding and Scientific Expertise Advance Company’s Clinical Development and Efforts Towards Commercialization SAN DIEGO–(BUSINESS WIRE)–May. 13, 2021 Bluestar Genomics, an innovative company leading the development of next-generation epigenomic approaches to early cancer detection, today announced the company had raised $70 million in new equity funding. Led with the increased funding by the current investor, […]

Business and Policy Leaders Sign Letter to President Biden Urging U.S. Leadership to Speed Global Vaccination Effort

NEW YORK–(BUSINESS WIRE)–May. 13, 2021 A group of 16 international business and policy leaders today published an open letter to U.S. President Joseph R. Biden calling on him to “demonstrate decisive U.S. leadership now” to combat increasingly deadly Covid-19 outbreaks in Latin America, Europe and Asia. This press release features multimedia. View the full release […]

SEASUN BIOMATERIALS Supplies On-site COVID-19 Rapid Molecular Diagnostic System to Seoul National University Campus

– ‘4S’ SEASUNBIO SMART SHIELD SYSTEM has been launched in SNU campus as the first mobile COVID-19 diagnostic center in Korea DAEJEON, South Korea–(BUSINESS WIRE)–May. 04, 2021 SEASUN BIOMATERIALS (CEO: Park Heekyung), a molecular diagnostic company has made its molecular diagnostic system ‘4S’ (SEASUNBIO SMART SHIELD SYSTEM) available at the Seoul National University (SNU) campus […]

Smiths Medical and Ivenix Partner to Revolutionize Infusion Management with First-Ever Comprehensive Suite of Infusion Solutions in US Healthcare Market

Bolstered by strategic investment from Smiths Medical, commercial partnership will offer best-in-class infusion systems designed to improve patient safety, advance clinical efficiency MINNEAPOLIS & BOSTON–(BUSINESS WIRE)–May. 04, 2021 Smiths Medical, a global medical device leader, today announced it has formed an exclusive partnership with Ivenix, Inc. that positions the companies as the first in the […]

RubrYc Therapeutics Announces a Research Collaboration and License Option Agreement With Zai Labs

SAN CARLOS, Calif.–(BUSINESS WIRE)–Apr. 14, 2021 RubrYc Therapeutics, Inc., a pre-clinical biotherapeutics company developing epitope selective therapies, today announced that it has entered into a research collaboration and license option agreement with Zai Labs, Inc. for the use of RubrYc’s Meso-scale Engineered Molecules (MEMs) platform, to identify monoclonal antibodies with enhanced biological function for an […]

LintonPharm Announces Authorization from China Health Authority (NMPA) to Proceed with a Phase 1/2 Trial Evaluating Catumaxomab for the treatment of Non-Muscle Invasive Bladder Cancer

GUANGZHOU, China–(BUSINESS WIRE)–Apr. 13, 2021 LintonPharm Co., Ltd., a China-based clinical stage biopharmaceutical company focused on the development of T cell engaging bispecific antibodies for cancer immunotherapy, today announced that China’s health authority, National Medical Products Administration (NMPA) authorized the company to proceed with a Phase 1/2 clinical trial (clinicaltrials.gov: NCT04799847) evaluating the safety and […]